Continuous epidural infusion of midazolam for postoperative analgesia in major gynaecological surgery: comparative study with ropivacaine
Medical Journal of Cairo University [The]. 2006; 74 (4 Supp. III): 287-291
Dans Anglais
| IMEMR
| ID: emr-79400
ABSTRACT
The study was conducted on 60 female patients who underwent major gynaecological operations. Postoperative analgesia was managed by epidural infusion of Ropivacaine 0.2% [Group R], Midazolam 0.02% [Group M] or a combination of Ropivacaine 0.2% + Midazolam 0.02% [Group RM] in a total infusion rate of 5mL/hour for 48 hours. Visual analogue scale, respiratory rate, heart rate, blood pressure, sedation score, SPO[2], PCO[2] and blood glucose level were monitored. Results showed that group RM had significant lower VAS value and lower need for rescue analgesics. Sedation was more pronounced in RM Group than the other ones with no respiratory adverse effects. In conclusion, adding Midazolam to continuous epidural infusion of Ropivacaine provides a great analgesic and sedative effect with no side effects
Recherche sur Google
Indice:
Méditerranée orientale
Sujet Principal:
Procédures de chirurgie gynécologique
/
Gazométrie sanguine
/
Midazolam
/
Bupivacaïne
/
Analgésie péridurale
/
Association médicamenteuse
/
Hémodynamique
Limites du sujet:
Femelle
/
Humains
langue:
Anglais
Texte intégral:
Med. J. Cairo Univ.
Année:
2006
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS